Understanding the frequency, risk factors, and management of anticoagulant-inducedadverse eventswill assist clinicians in optimizing patient outcomes. The most frequent adverse event of all anticoagulants is major bleeding. Risk factors for major bleeding have been identified with the heparin com-pounds, the direct thrombin inhibitors (DTIs), fondaparinux, and warfarin therapy. Understanding these risk factors can help prevent bleeding events. For cases of clinically signifi-cant bleeding, reversal agents exist primarily for heparin and warfarin. Although less common, nonbleeding adverse events of anticoagulant therapy can also be life threatening. The heparin compounds are associated with the develop-ment of heparin-induced thrombocytopeni...
Since affecting hemostasis, all the anticoagulant drugs carry a risk of bleeding. Minor bleeds may b...
Since affecting hemostasis, all the anticoagulant drugs carry a risk of bleeding. Minor bleeds may b...
The Author(s) 2013. This article is published with open access at Springerlink.com Abstract Anticoag...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
This article about hemorrhagic complications of anticoagulant and thrombolytic treatment is part of ...
Contains fulltext : 98000.pdf (publisher's version ) (Open Access)Bleeding is the ...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists...
Since affecting hemostasis, all the anticoagulant drugs carry a risk of bleeding. Minor bleeds may b...
Since affecting hemostasis, all the anticoagulant drugs carry a risk of bleeding. Minor bleeds may b...
The Author(s) 2013. This article is published with open access at Springerlink.com Abstract Anticoag...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case...
This article about hemorrhagic complications of anticoagulant and thrombolytic treatment is part of ...
Contains fulltext : 98000.pdf (publisher's version ) (Open Access)Bleeding is the ...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
The majority of patients with venous thromboembolism (VTE) have a considerable long-term risk of rec...
Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists...
Since affecting hemostasis, all the anticoagulant drugs carry a risk of bleeding. Minor bleeds may b...
Since affecting hemostasis, all the anticoagulant drugs carry a risk of bleeding. Minor bleeds may b...
The Author(s) 2013. This article is published with open access at Springerlink.com Abstract Anticoag...